Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr Basu Chakrabarty
University of Bristol

ICS 2023

Podium Session 14 Best Pure and Applied Science 107 Role of the nitric oxide/cGMP pathway in the selective reduction of ATP neurotransmitter release in mouse detrusor

ICS 2021

Open Discussion Session 30 On Demand Pharmacology 475 Frequency-dependent characteristics of nerve-mediated ATP and ACh release in mouse detrusor

ICS 2020

Podium Short Oral Session 11 Therapeutic Mechanisms 164 The modulation of cAMP by adenosine inhibits neuronal ATP release from efferent nerve terminals to the detrusor of mouse bladder

Podium Session 19 Best Basic Science 256 Modulating cGMP and protein kinase G (PKG) attenuates nerve-mediated ATP release, and not ACh release, in the mouse detrusor

ICS 2019

Open Discussion Session 31 E-Poster 3 647 The effects of adenosine and modulation of A1 receptor activity on nerve-mediated contractions and ATP release in the bladder

Open Discussion Session 31 E-Poster 3 648 The effects of sildenafil and the NO/cGMP pathway on nerve-mediated contractions and ATP neurotransmitter release in the mouse bladder

ICS 2018

Podium Short Oral Session 11 Basic Science: Neurourology 224 Sildenafil reduces pre- and post-ganglionic stimulated contractions in the mouse urinary bladder

ICS 2017

Podium Short Oral Session 2 Lower Urinary Tract and Therapeutics 16 The effects of sildenafil on bladder contractility and neuronal ATP release in the mouse urinary bladder

ICS 2013

Podium Poster Session 28 Male 2 255 Zone-specific differences in spontaneous contractility of the human prostate gland

Basu Chakrabarty

ICS Member (Expired)

Profession:Research Scientist
Qualifications:PhD Staff Member
Privacy:
You must be logged in to view this contact
Sign-in to ICS

Dr Basu Chakrabarty is a Postdoctoral Research Associate at the School of Physiology, Pharmacology & Neuroscience, Faculty of Life Sciences, at the University of Bristol, Bristol, UK, with a specific interest in urogenital physiology and pharmacology. Basu completed a Bachelor in Pharmaceutical Science (Formulation Chemistry), Honours Degree in Bachelor of Pharmaceutical Science (Pharmaceutical Biology), and subsequently a PhD (Drug Discovery Biology) at Monash University, Faculty of Pharmacy and Pharmaceutical Sciences in Melbourne, Australia. Basu’s interests include urogenital physiology and pharmacology – bladder, urethra and prostate, vascular smooth muscle physiology and biomechanics, autonomic pharmacology, and cellular signalling.

NO DISCLOSURE STATEMENT RECORDED
VOLUNTARY